C3 Glomerulonephritis/CFHR5 Nephropathy Is an Endemic Disease in Cyprus: Clinical and Molecular Findings in 21 Families

  • Constantinos DeltasEmail author
  • Daniel Gale
  • Terence Cook
  • Konstantinos Voskarides
  • Yiannis Athanasiou
  • Alkis Pierides
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 735)


Microscopic haematuria is the presenting symptom of several conditions, either heritable or acquired. A well-recognized familial condition is Alport syndrome, either of X-linked or autosomal recessive inheritance, as well as thin basement membrane nephropathy (TBMN) because of heterozygous collagen IV mutations. Even though microscopic haematuria of TBMN was long considered as a benign disease with excellent prognosis, more recent data suggest that development of chronic kidney disease (CKD) and even end-stage kidney disease (ESKD) is not a rare finding, perhaps owing to the cofounding role of modifier genes and other factors. Recent investigations in London and Cyprus culminated in the identification of another autosomal dominant condition that presents with microscopic haematuria because of heterozygous mutations in the CFHR5 gene, which apparently plays a pivotal role in the regulation of the alterative pathway of complement system, which constitutes a significant part of innate immunity in humans. Histologically, the hallmark observation is the isolated glomerular deposition of C3 complement in the absence of immune complexes. It is considered one of the C3 glomerulopathies, and it may or may not be accompanied by mild membranoproliferative glomerulonephritis. Interestingly, a single mutation has been identified so far, a duplication of exons 2–3 of the CFHR5 gene, and it has been described in patients of Greek-Cypriot descend only, perhaps originating on the Troodos mountains of Cyprus. Thus far, no patient with a mutation in this gene has been diagnosed in any other population. In Cyprus, it has been found in clusters of families in neighbouring villages in a total of 136 patients, and it constitutes a strong founder phenomenon. About 50% of patients over 50 years have progressed to CKD, and 14% of all patients progressed to ESKD. It is not quite well understood why males run a much higher risk to progress to CKD, compared to women.


Chronic Kidney Disease Microscopic Haematuria Alport Syndrome Alternative Complement Pathway Focal Segmental Glomerular Sclerosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Athanasiou Y, Voskarides K, Gale D, Damianou L, Patsias C, Zavros M et al (2011) Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees. Clin J Am Soc Nephrol 6:1436–1446CrossRefGoogle Scholar
  2. Deltas C (2004) Inherited diseases and Cyprus reality. A historico-genetic approach. In: The 30th annals of the Cyprus Research Center (Epetirida), Ministry of Education and Culture, Nicosia, Cyprus (Greek), pp 457–489Google Scholar
  3. Deltas C, Pierides A, Voskarides K (2012) The role of molecular genetics in diagnosing familial hematuria(s). Pediatr Nephrol, DOI:  10.1007/s00467-011-1935-5
  4. Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, Adam G et al (2010) Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 376:794–801CrossRefGoogle Scholar
  5. Grekas D, Morley AR, Wilkinson R, Kerr DN (1984) Isolated C3 deposition in patients without systemic disease. Clin Nephrol 21:270–274PubMedGoogle Scholar
  6. Murphy B, Georgiou T, Machet D, Hill P, McRae J (2002) Factor H-related protein-5: a novel component of human glomerular immune deposits. Am J Kidney Dis 39:24–27CrossRefGoogle Scholar
  7. Kashtan CE (2005) Familial hematurias: what we know and what we don’t. Pediatr Nephrol 20:1027–1035CrossRefGoogle Scholar
  8. Papagregoriou G, Erguler K, Dweep H, Voskarides K, Koupepidou P, Athanasiou A et al (2012) A miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathy. PLoS ONE 7(2):e31021 [Epub 2012 Feb 2] CrossRefGoogle Scholar
  9. Pierides A, Voskarides K, Athanasiou Y, Ioannou K, Damianou L, Arsali M et al (2009) Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis. Nephrol Dial Transplant 24:2721–2729CrossRefGoogle Scholar
  10. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:e57CrossRefGoogle Scholar
  11. Servais A, Frémeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B et al (2007) Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet 44:193–199CrossRefGoogle Scholar
  12. Voskarides K, Damianou L, Neocleous V, Zouvani I, Christodoulidou S, Hadjiconstantinou V et al (2007) COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy. J Am Soc Nephrol 18:3004–3016CrossRefGoogle Scholar
  13. Voskarides Κ, Patsias C, Pierides A, Deltas C (2008) COL4A3 Founder mutations in Greek-Cypriot families with thin basement membrane nephropathy and focal segmental glomerulosclerosis dating from around 18th century. Genet Test 12(2):273–278CrossRefGoogle Scholar
  14. Voskarides K, Arsali M, Athanasiou Y, Elia A, Pierides A, Deltas C (2012) Evidence that NPHS2-R229Q predisposes to proteinuria and renal failure in familial hematuria. Pediatr Nephrol, DOI:  10.1007/s00467-011-2084-6

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Constantinos Deltas
    • 1
    Email author
  • Daniel Gale
    • 2
  • Terence Cook
    • 2
  • Konstantinos Voskarides
    • 1
  • Yiannis Athanasiou
    • 3
  • Alkis Pierides
    • 4
  1. 1.Molecular Medicine Research Center and Laboratory of Molecular and Medical Genetics, Department of Biological SciencesUniversity of CyprusNicosiaCyprus
  2. 2.Imperial College Kidney and Transplant InstituteLondonUK
  3. 3.Department of NephrologyNicosia General HospitalNicosiaCyprus
  4. 4.Department of NephrologyHippocrateon HospitalNicosiaCyprus

Personalised recommendations